As mpox spreads, ‘national governments have a moral responsibility to help’
As the number of mpox-related deaths in the Democratic Republic of Congo (DRC) and neighbouring countries continues to climb, international…
Macro
-
-
Q2 2024 update: social responsibility related hiring actvity in the pharma industry
The global pharmaceutical industry experienced a 22% rise in new job postings related to social responsibility in Q2 2024 compared…
-
Q2 2024 update: environmental sustainability related hiring actvity in the pharma industry
The global pharmaceutical industry experienced a 17% rise in new job postings related to environmental sustainability in Q2 2024 compared…
-
What is mpox and how big of a threat is it?
Mostly centred in the Democratic Republic of Congo DRC) and its African neighbours, the current outbreak of mpox has been…
-
Entos and Aegis announce dosing of first subject in Covid-19 vaccine trial
Entos Pharmaceuticals and its partner Aegis Life have announced the first subject dosing in the Phase I/II clinical trial of…
-
AB Science touts positive Phase II Covid-19 data for masitinib
AB Science has announced positive data from the Phase II trial investigating lead asset masitinib in hospitalised Covid-19 patients, highlighting…
-
NIH announces start of subject enrolment for nasal Covid-19 vaccine trial
The US National Institutes of Health (NIH) has announced the start of subject enrolment for a Phase I clinical trial…
-
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
CyanVac has received US federal funding through the Project NextGen initiative to conduct a Phase IIb comparative clinical trial of…
-
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Moderna has announced that its Phase III clinical trial of the investigational next-generation Covid-19 vaccine, mRNA-1283, met its primary efficacy…
-
Health Canada grants approval to Entos for Covid-19 vaccine booster trial
Health Canada has granted approval to Entos Pharmaceuticals to commence a Phase I/II clinical trial of its investigational Covid-19 vaccine…
